PL2822964T3 - Identyfikacja mutacji opsyny kanałowej 2 (chop2) i sposoby stosowania - Google Patents
Identyfikacja mutacji opsyny kanałowej 2 (chop2) i sposoby stosowaniaInfo
- Publication number
- PL2822964T3 PL2822964T3 PL13710253T PL13710253T PL2822964T3 PL 2822964 T3 PL2822964 T3 PL 2822964T3 PL 13710253 T PL13710253 T PL 13710253T PL 13710253 T PL13710253 T PL 13710253T PL 2822964 T3 PL2822964 T3 PL 2822964T3
- Authority
- PL
- Poland
- Prior art keywords
- chop2
- channelrhodopsin
- mutations
- identification
- methods
- Prior art date
Links
- 230000035772 mutation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261606663P | 2012-03-05 | 2012-03-05 | |
| PCT/US2013/029171 WO2013134295A1 (en) | 2012-03-05 | 2013-03-05 | Identification of channelrhodopsin-2 (chop2) mutations and methods of use |
| EP13710253.9A EP2822964B1 (en) | 2012-03-05 | 2013-03-05 | Identification of channelrhodopsin-2 (chop2) mutations and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2822964T3 true PL2822964T3 (pl) | 2019-05-31 |
Family
ID=47892055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13710253T PL2822964T3 (pl) | 2012-03-05 | 2013-03-05 | Identyfikacja mutacji opsyny kanałowej 2 (chop2) i sposoby stosowania |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US10947281B2 (https=) |
| EP (1) | EP2822964B1 (https=) |
| JP (3) | JP6395611B2 (https=) |
| KR (1) | KR102137717B1 (https=) |
| CN (2) | CN104334575A (https=) |
| AU (4) | AU2013230112A1 (https=) |
| CA (1) | CA2866405A1 (https=) |
| DK (1) | DK2822964T3 (https=) |
| EA (1) | EA201491643A1 (https=) |
| ES (1) | ES2703324T3 (https=) |
| HU (1) | HUE040487T2 (https=) |
| MX (1) | MX360085B (https=) |
| NZ (1) | NZ629843A (https=) |
| PL (1) | PL2822964T3 (https=) |
| PT (1) | PT2822964T (https=) |
| WO (1) | WO2013134295A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2019588A4 (en) | 2006-05-04 | 2010-11-24 | Univ Wayne State | RESTORATION OF VISUAL RESPONSES BY IN VIVO ADMINISTRATION OF NUCLEIC ACIDS OF RHODOPSIN |
| WO2011140279A1 (en) | 2010-05-04 | 2011-11-10 | Wayne State University | Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells |
| AU2013230112A1 (en) | 2012-03-05 | 2014-09-25 | Wayne State University | Identification of channelrhodopsin-2 (Chop2) mutations and methods of use |
| US9730888B2 (en) | 2013-03-14 | 2017-08-15 | Wayne State University | Method of enhancing delivery of therapeutic compounds to the eye |
| JP6469669B2 (ja) | 2013-07-08 | 2019-02-13 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | オキシムエステル光開始剤 |
| AU2015229464B2 (en) | 2014-03-11 | 2021-07-22 | Wayne State University | A modified mGluR6 promoter and methods of use |
| RU2018142273A (ru) | 2016-05-03 | 2020-06-03 | Чжо-хуа Пань | Способ улучшения опосредованной вирусами доставки генов в глаз с использованием ингибиторов протеасом |
| WO2017207745A1 (en) * | 2016-06-03 | 2017-12-07 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Mutant light-inducible ion channel of channelrhodopsin |
| CA3034887A1 (en) * | 2016-08-29 | 2018-03-08 | Wayne State University | Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof |
| WO2018106369A2 (en) * | 2016-11-06 | 2018-06-14 | Nanoscope Technologies Llc | Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof |
| EP3609518A1 (en) * | 2017-04-12 | 2020-02-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | New optogenetic tool |
| SI3720428T1 (sl) * | 2017-12-04 | 2023-05-31 | Laboratorios Salvat, S. A. | Oftalmični lokalni sestavek, ki vsebuje dobesilno kislino za zdravljenje bolezni posteriornega očesnega segmenta |
| JP6567153B1 (ja) * | 2018-09-28 | 2019-08-28 | 学校法人東北工業大学 | 対象化合物の特性の予測を行うための方法、コンピュータシステム、プログラム |
| WO2024226667A2 (en) * | 2023-04-24 | 2024-10-31 | Nanoscope Therapeutics Inc. | Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4498919A (en) | 1983-10-31 | 1985-02-12 | Corning Glass Works | Method for making colored photochromic prescription ophthalmic lenses |
| US6610287B1 (en) | 1990-04-16 | 2003-08-26 | The General Hospital Corporation | Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
| US5827702A (en) | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
| CA2287495A1 (en) | 1997-04-21 | 1998-10-29 | University Of Florida | Materials and methods for treatment of retinal diseases |
| WO2000015822A1 (en) | 1998-09-17 | 2000-03-23 | University Of Florida | Methods for treatment of degenerative retinal diseases |
| CA2406743A1 (en) | 2000-04-28 | 2001-11-08 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| CA2442670A1 (en) | 2001-04-13 | 2002-10-24 | The Trustees Of The University Of Pennsylvania | Method of treating or retarding the development of blindness |
| WO2003016486A2 (en) | 2001-08-16 | 2003-02-27 | Sloan Kettering Institute For Cancer Research | Bio-synthetic photostimulators and methods of use |
| DE10216005A1 (de) | 2002-04-11 | 2003-10-30 | Max Planck Gesellschaft | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| AU2003249318A1 (en) | 2002-07-18 | 2004-02-09 | The General Hospital Corp. | Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| US7186699B2 (en) | 2003-06-03 | 2007-03-06 | Cell Genesys, Inc. | Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| JP2007527738A (ja) | 2003-11-05 | 2007-10-04 | ニューロヴィジョン， インコーポレイテッド | 視覚を改善するための方法および装置 |
| EP1919497B1 (en) | 2005-07-22 | 2020-02-12 | The Board of Trustees of the Leland Stanford Junior University | Light-activated cation channel and uses thereof |
| EP2019588A4 (en) | 2006-05-04 | 2010-11-24 | Univ Wayne State | RESTORATION OF VISUAL RESPONSES BY IN VIVO ADMINISTRATION OF NUCLEIC ACIDS OF RHODOPSIN |
| WO2011140279A1 (en) * | 2010-05-04 | 2011-11-10 | Wayne State University | Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells |
| PL2614079T3 (pl) * | 2010-09-08 | 2016-01-29 | Max Planck Gesellschaft | Zmutowana kanałowa rodopsyna 2 |
| AU2013230112A1 (en) * | 2012-03-05 | 2014-09-25 | Wayne State University | Identification of channelrhodopsin-2 (Chop2) mutations and methods of use |
| KR101639859B1 (ko) * | 2014-03-06 | 2016-07-14 | 포항공과대학교 산학협력단 | 광 자극에 의한 미토콘드리아 활성의 시공간적 가역 조절 방법 |
-
2013
- 2013-03-05 AU AU2013230112A patent/AU2013230112A1/en not_active Abandoned
- 2013-03-05 KR KR1020147027985A patent/KR102137717B1/ko active Active
- 2013-03-05 PT PT13710253T patent/PT2822964T/pt unknown
- 2013-03-05 MX MX2014010664A patent/MX360085B/es active IP Right Grant
- 2013-03-05 CA CA2866405A patent/CA2866405A1/en active Pending
- 2013-03-05 ES ES13710253T patent/ES2703324T3/es active Active
- 2013-03-05 WO PCT/US2013/029171 patent/WO2013134295A1/en not_active Ceased
- 2013-03-05 HU HUE13710253A patent/HUE040487T2/hu unknown
- 2013-03-05 CN CN201380022635.5A patent/CN104334575A/zh active Pending
- 2013-03-05 PL PL13710253T patent/PL2822964T3/pl unknown
- 2013-03-05 US US14/383,211 patent/US10947281B2/en active Active
- 2013-03-05 EA EA201491643A patent/EA201491643A1/ru unknown
- 2013-03-05 NZ NZ629843A patent/NZ629843A/en unknown
- 2013-03-05 DK DK13710253.9T patent/DK2822964T3/en active
- 2013-03-05 JP JP2014561051A patent/JP6395611B2/ja active Active
- 2013-03-05 CN CN202010025519.0A patent/CN111378020A/zh active Pending
- 2013-03-05 EP EP13710253.9A patent/EP2822964B1/en active Active
-
2017
- 2017-10-06 AU AU2017239601A patent/AU2017239601B2/en active Active
-
2018
- 2018-04-23 JP JP2018082403A patent/JP2018134098A/ja not_active Withdrawn
-
2019
- 2019-07-01 JP JP2019123061A patent/JP2019193656A/ja active Pending
- 2019-08-14 AU AU2019216638A patent/AU2019216638B2/en active Active
-
2021
- 2021-03-15 US US17/202,064 patent/US20220033449A1/en not_active Abandoned
- 2021-10-07 AU AU2021245195A patent/AU2021245195B2/en active Active
-
2024
- 2024-04-18 US US18/639,381 patent/US20250066431A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2822964T3 (pl) | Identyfikacja mutacji opsyny kanałowej 2 (chop2) i sposoby stosowania | |
| SG10201609940RA (en) | Compounds and their methods of use | |
| ES3063081T3 (en) | Anti-cd47 antibodies and methods of use thereof | |
| ZA201501858B (en) | Anti-mcam antibodies and associated methods of use | |
| HUE046178T2 (hu) | Biomátrix hidrogélek és alkalmazási eljárásaik | |
| ZA201405248B (en) | Anesthetic compounds and related methods of use | |
| EP2791333A4 (en) | OPSINE POLYPEPTIDES AND METHODS OF USE | |
| ZA201404675B (en) | Anti-lrp5 antibodies and methods of use | |
| SG11201500051PA (en) | Wireless stethoscope and method of use thereof | |
| SG11201406894VA (en) | Oilfield apparatus and methods of use | |
| ZA201405858B (en) | Recombinant microorganisms and methods of use thereof | |
| SG11201502757QA (en) | Anti-c16orf54 antibodies and methods of use thereof | |
| EP2806811A4 (en) | VERTEBRAL CONSTRUCTION | |
| ZA201500295B (en) | Devices and methods for enhanced detection and identification of diseases | |
| IL234841A0 (en) | Administration forms of halofuginone and methods of use | |
| SG10201608970SA (en) | Oilfield apparatus and methods of use | |
| AP2015008460A0 (en) | Apparatus and methods of enhanced mobility management | |
| IL239043A0 (en) | Thrombin solution and methods of using it | |
| ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
| ZA201405644B (en) | Weatherised minerals and methods of making and using same | |
| GB201222855D0 (en) | Lock Means and Method of Use Thereof | |
| GB201210911D0 (en) | Clamping means and method of use thereof | |
| GB201203663D0 (en) | Note pad and method of use thereof |